CT and MRI of brain tumors

Quarterly Journal of Nuclear Medicine and Molecular Imaging

Volumn 56, Issue 2, 2012, Pages 112-137

  Bruzzone, M G ^a   D'Incerti, L ^a   Farina, L L ^a   Cuccarini, V ^a   Finocchiaro, G ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Brain neoplasms; Diffusion magnetic resonance imaging; Magnetic resonance imaging; Magnetic resonance spectroscopy; Tomography, x ray computed

Indexed keywords

ACOUSTIC NEURINOMA; ARACHNOID CYST; ASTROCYTOMA; BOLD SIGNAL; BONE METASTASIS; BRAIN METASTASIS; BRAIN TUMOR; CANCER GRADING; CANCER PATIENT; CHORDOMA; CHOROID PLEXUS TUMOR; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CRANIOPHARYNGIOMA; CRANIOTOMY; CYTOARCHITECTURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; EPIDERMOID CYST; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GANGLIONEUROMA; GERM CELL TUMOR; GLIOBLASTOMA; GLIOMA; GLIOSIS; HEMODYNAMICS; HUMAN; INTRAOPERATIVE PERIOD; MAGNETIC RESONANCE ANGIOGRAPHY; MEDULLOBLASTOMA; MENINGEAL METASTASIS; MENINGIOMA; NEURILEMOMA; NEUROIMAGING; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; PERFUSION WEIGHTED IMAGING; PILOCYTIC ASTROCYTOMA; PREOPERATIVE EVALUATION; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PROGNOSIS; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SURGEON; SURGICAL APPROACH; SURGICAL RISK; TERATOMA; TREATMENT RESPONSE;

BRAIN; BRAIN NEOPLASMS; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84864378257     PISSN: 18244785     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (110)

1. Guo AC, MacFall JR, Provenzale JM. Multiple sclerosis: diffusion tensor MR imaging for evaluation of normal-appearing white matter. Radiology 2002;222:729-36. (Pubitemid 34215221)
2. Weber MA, Giesel FL, Stieltjes B. MRI for identification of progression in brain tumors: from morphology to function. Expert Rev Neurother 2008;8:1507-25.
3. Brunberg JA, Chenevert TL, McKeever PE, Ross DA, Junck LR, Muraszko KM et al. In vivo MR determination of water diffusion coefficients and diffusion anisotropy: correlation with structural alteration in gliomas of the cerebral hemispheres. AJNR Am J Neuroradiol 1995;16:361-71.
4. Cha S. Update on brain tumor imaging: from anatomy to physiology. AJNR Am J Neuroradiol 2006;27:475-87. (Pubitemid 44897763)
5. Kim JH, Chang KH, Na DG, Song IC, Kwon BJ, Han MH et al. 3T 1H-MR spectroscopy in grading of cerebral gliomas: comparison of short and intermediate echo time sequences. AJNR Am J Neuroradiol 2006;27:1412-8. (Pubitemid 44260119)
6. Cha S. Perfusion MR imaging of brain tumors. Top Magn Reson Imaging 2004;15:279-89.
7. Law M, Yang S, Babb JS, Knopp EA, Golfinos JG, Zagzag D et al. Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 2004;25:746-55. (Pubitemid 38657655)
8. Caseiras GB, Chheang S, Babb J, Rees JH, Pecerrelli N, Tozer DJ et al. Relative cerebral blood volume measurements of low-grade gliomas predict patient outcome in a multi-institution setting. Eur J Radiol 2010;73:215-20.
9. Howe FA, Opstad KS 1H MR spectroscopy of brain tumours and masses. NMR Biomed 2003;16:123-31.
10. Li X, Lu Y, Pirzkall A, McKnight T, Nelson SJ. Analysis of the spatial characteristics of metabolic abnormalities in newly diagnosed glioma patients. J Magn Reson Imaging 2002;16:229-37. (Pubitemid 34920420)
11. Cha S. Neuroimaging in neuro-oncology. Neurotherapeutics 2009;6:465-77.
12. Law M, Yang S, Wang H, Babb JS, Johnson G, Cha S et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 2003;24:1989-98. (Pubitemid 37444849)
13. Sunaert S. Presurgical planning for tumor resectioning. J Magn Reson Imaging 2006;23:887-905. (Pubitemid 43833158)
14. Behin A, Hoang-Xuan K, Carpentier AF, Delattre JY. Primary brain tumours in adults. Lancet 2003;361:323-31. (Pubitemid 36126198)
15. Essig M, Anzalone N, Combs SE, Dorfler A, Lee SK, Picozzi P et al. MR Imaging of Neoplastic Central Nervous System Lesions: Review and Recommendations for Current Practice. AJNR Am J Neuroradiol 2011.
16. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007;114:97-109. (Pubitemid 47103521)
17. Longstreth WT, Jr., Dennis LK, McGuire VM, Drangsholt MT, Koepsell TD. Epidemiology of intracranial meningioma. Cancer 1993;72:639-48. (Pubitemid 23215245)
18. Macdonald DR, Cascino TL, Schold SC, Jr., Cairncross JG. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 1990;8:1277-80. (Pubitemid 20195640)
19. Shah GD, Kesari S, Xu R, Batchelor TT, O'Neill AM, Hochberg FH et al. Comparison of linear and volumetric criteria in assessing tumor response in adult high-grade gliomas. Neuro Oncol 2006;8:38-46. (Pubitemid 43154449)
20. Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E et al. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 2010;28:1963-72.
21. Lang FF, Gilbert MR. Diffusely infiltrative low-grade gliomas in adults. J Clin Oncol 2006;24:1236-45. (Pubitemid 46622026)
22. Ullrich RT, Kracht LW, Jacobs AH. Neuroimaging in patients with gliomas. Semin Neurol 2008;28:484-94.
23. Bruzzone MG, Eoli M, Cuccarini V, Grisoli M, Valletta L, Finocchiaro G. Genetic signature of adult gliomas and correlation with MRI features. Expert Rev Mol Diagn 2009;9:709-20.
24. Barajas RF, Jr., Hodgson JG, Chang JS, Vandenberg SR, Yeh RF, Parsa AT et al. Glioblastoma multiforme regional genetic and cellular expression patterns: influence on anatomic and physiologic MR imaging. Radiology 2010;254:564-76.
25. Bulakbasi N, Guvenc I, Onguru O, Erdogan E, Tayfun C, Ucoz T. The added value of the apparent diffusion coefficient calculation to magnetic resonance imaging in the differentiation and grading of malignant brain tumors. J Comput Assist Tomogr 2004;28:735-46. (Pubitemid 39489910)
26. Zonari P, Baraldi P, Crisi G. Multimodal MRI in the characterization of glial neoplasms: the combined role of single-voxel MR spectroscopy, diffusion imaging and echo-planar perfusion imaging. Neuroradiology 2007;49:795-803. (Pubitemid 47497767)
27. Senft C, Hattingen E, Pilatus U, Franz K, Schanzer A, Lanfermann H et al. Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values. Neurosurgery 2009;65:908-13; discussion 13.
28. Henson JW, Gaviani P, Gonzalez RG. MRI in treatment of adult gliomas. Lancet Oncol 2005;6:167-75. (Pubitemid 40305384)
29. Alvarez-Linera J, Benito-Leon J, Escribano J, Rey G. Predicting the histopathological grade of cerebral gliomas using high b value MR DW imaging at 3-tesla. J Neuroimaging 2008;18:276-81.
30. Fan GG, Deng QL, Wu ZH, Guo QY. Usefulness of diffusion/perfusion- weighted MRI in patients with non-enhancing supratentorial brain gliomas: a valuable tool to predict tumour grading? Br J Radiol 2006;79:652-8. (Pubitemid 44283154)
31. Arvinda HR, Kesavadas C, Sarma PS, Thomas B, Radhakrishnan W, Gupta AK et al. Glioma grading: sensitivity, specificity, positive and negative predictive values of diffusion and perfusion imaging. Journal of neuro-oncology 2009;94:87-96.
32. Eoli M, Menghi F, Bruzzone MG, De Simone T, Valletta L, Polio B et al. Methylation of 06-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival. Clin Cancer Res 2007;13:2606-13. (Pubitemid 46788026)
33. Server A, Kulle B, Gadmar OB, Josefsen R, Kumar T, Nakstad PH. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas. Eur J Radiol 2011;80:462-70.
34. Rollin N, Guyotat J, Streichenberger N, Honnorat J, Tran Minh VA, Cotton F. Clinical relevance of diffusion and perfusion magnetic resonance imaging in assessing intra-axial brain tumors. Neuroradiology 2006148:150-9.
35. Rizzo L, Crasto SG, Moruno PG, Cassoni P, Ruda R, Boccaletti R et al. Role of diffusion- and perfusion-weighted MR imaging for brain tumour characterisation. Radiol Med 2009;114:645-59.
36. Hakyemez B, Erdogan C, Ercan I, Ergin N, Uysal S, Atahan S. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging. Clin Radiol 2005;60:493-502. (Pubitemid 40353027)
37. Di Costanzo A, Pollice S, Trojsi F, Giannatempo GM, Popolizio T, Canalis L et al. Role of perfusion-weighted imaging at 3 Tesla in the assessment of malignancy of cerebral gliomas. Radiol Med 2008;113:134-43. (Pubitemid 351387215)
38. Chang SM, Nelson S, Vandenberg S, Cha S, Prados M, Butowski N et al. Integration of preoperative anatomic and metabolic physiologic imaging of newly diagnosed glioma. Journal of neuro-oncology 2009;92:401-15.
39. Cha S, Tihan T, Crawford F, Fischbein NJ, Chang S, Bollen A et al. Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging. AJNR Am J Neuroradiol 2005;26:266-73. (Pubitemid 43073303)
40. Hlaihel C, Guilloton L, Guyotat J, Streichenberger N, Honnorat J, Cotton F. Predictive value of multimodality MRI using conventional, perfusion, and spectroscopy MR in anaplastic transformation of low-grade oligodendrogliomas. Journal of neurooncology 2010;97:73-80.
41. McKnight TR, Lamborn KR, Love TD, Berger MS, Chang S, Dillon WP et al. Correlation of magnetic resonance spectroscopic and growth characteristics within Grades II and III gliomas. J Neurosurg 2007;106:660-6. (Pubitemid 46536464)
42. Koeller KK, Rushing EJ. From the archives of the AFIP: pilocytic astrocytoma: radiologic-pathologic correlation. Radiographics 2004;24:1693-708.
43. Listernick R, Louis DN, Packer RJ, Gutmann DH. Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force. Ann Neurol 1997;41:143-9. (Pubitemid 27082094)
44. Porto L, Kieslich M, Franz K, Lehrbecher T, Pilatus U, Hattingen E. Proton magnetic resonance spectroscopic imaging in pediatric low-grade gliomas. Brain Tumor Pathol 2010;27:65-70.
45. Cho SK, Na DG, Ryoo JW, Roh HG, Moon CH, Byun HS et al. Perfusion MR imaging: clinical utility for the differential diagnosis of various brain tumors. Korean J Radiol 2002;3:171-9.
46. Pallud J, Capelle L, Taillandier L, Fontaine D, Mandonnet E, Guillevin R et al. Prognostic significance of imaging contrast enhancement for WHO grade II gliomas. Neuro Oncol 2009;11:176-82.
47. Eoli M, Bissola L, Bruzzone MG, Polio B, Maccagnano C, De Simone T et al. Reclassification of oligoastrocytomas by loss of heterozygosity studies. Int J Cancer 2006;119:84-90.
48. McKnight TR, Smith KJ, Chu PW, Chiu KS, Cloyd CP, Chang SM et al. Choline metabolism, proliferation, and angiogenesis in nonenhancing grades 2 and 3 astrocytoma. J Magn Reson Imaging 2011;33:808-16.
49. Howe FA, Barton SJ, Cudlip SA, Stubbs M, Saunders DE, Murphy M et al. Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med 2003;49:223-32. (Pubitemid 36159858)
50. Righi V, Roda JM, Paz J, Mucci A, Tugnoli V, Rodriguez-Tarduchy G et al 1H HR-MAS and genomic analysis of human tumor biopsies discriminate between high and low grade astrocytomas. NMR Biomed 2009;22:629-37.
51. Shin JH, Lee HK, Khang SK, Kim DW, Jeong AK, Ahn KJ et al. Neuronal tumors of the central nervous system: radiologic findings and pathologic correlation. Radiographics 2002;22:1177-89.
52. Cianfoni A, Wintermark M, Piludu F, D'Alessandris QG, Lauriola L, Visocchi M et al. Morphological and functional MR imaging of Lhermitte-Duclos disease with pathology correlate. J Neuroradiol 2008;35:297-300.
53. Kerkovsky M, Zitterbart K, Svoboda K, Hrivnacka J, Skotakova J, Sprlakova-Pukova A et al. Central neurocytoma: the neuroradiological perspective. Childs Nerv Syst 2008;24:1361-9.
54. Zhang D, Henning TD, Zou LG, Hu LB, Wen L, Feng XY et al. Intracranial ganglioglioma: clinicopathological and MRI findings in 16 patients. Clin Radiol 2008;63:80-91. (Pubitemid 350212868)
55. Fellah S, Callot V, Viout P, Confort-Gouny S, Scavarda D, Dory-Lautrec P et al. Epileptogenic brain lesions in children: the added-value of combined diffusion imaging and proton MR spectroscopy to the presurgical differential diagnosis. Childs Nerv Syst 2011.
56. Smith AB, Rushing EJ, Smirniotopoulos JG. From the archives of the AFIP: lesions of the pineal region: radiologic-pathologic correlation. Radiographics 2010;30:2001-20.
57. Liang L, Korogi Y, Sugahara T, Ikushima I, Shigematsu Y, Okuda T et al. MRI of intracranial germ-cell tumours. Neuroradiology 2002;44:382-8. (Pubitemid 36097187)
58. Osborn AG, Preece MT. Intracranial cysts: radiologic-pathologic correlation and imaging approach. Radiology 2006;239:650-64. (Pubitemid 43830600)
59. Engel U, Gottschalk S, Niehaus L, Lehmann R, May C, Vogel S et al. Cystic lesions of the pineal region - MRI and pathology. Neuroradiology 2000;42:399-402. (Pubitemid 30438688)
60. Fakhran S, Escott EJ. Pineocytoma mimicking a pineal cyst on imaging: true diagnostic dilemma or a case of incomplete imaging? AJNR Am J Neuroradiol 2008;29:159-63.
61. Zhang D, Hu LB, Henning TD, Ravarani EM, Zou LG, Feng XY et al. MRI findings of primary CNS lymphoma in 26 immunocompetent patients. Korean J Radiol 2010;11:269-77.
62. Koeller KK, Smirniotopoulos JG, Jones RV. Primary central nervous system lymphoma: radiologic-pathologic correlation. Radiographics 1997;17:1497-526. (Pubitemid 127466070)
63. Coulon A, Lafitte F, Hoang-Xuan K, Martin-Duverneuil N, Mokhtari K, Blustajn J et al. Radiographic findings in 37 cases of primary CNS lymphoma in immunocompetent patients. Eur Radiol 2002;12:329-40. (Pubitemid 36940068)
64. Haque S, Law M, Abrey LE, Young RJ. Imaging of lymphoma of the central nervous system, spine, and orbit. Radiol Clin North Am 2008;46:339-61, ix. (Pubitemid 351932047)
65. Akter M, Hirai T, Makino K, Kitajima M, Murakami R, Fukuoka H et al. Diffusion-weighted imaging of primary brain lymphomas: effect of ADC value and signal intensity of T2-weighted imaging. Comput Med Imaging Graph 2008;32:539-43.
66. Toh CH, Castillo M, Wong AM, Wei KC, Wong HF, Ng SH et al. Primary cerebral lymphoma and glioblastoma multiforme: differences in diffusion characteristics evaluated with diffusion tensor imaging. AJNR Am J Neuroradiol 2008;29:471-5. (Pubitemid 351424059)
67. Kinoshita M, Hashimoto N, Goto T, Kagawa N, Kishima H, Izumoto S et al. Fractional anisotropy and tumor cell density of the tumor core show positive correlation in diffusion tensor magnetic resonance imaging of malignant brain tumors. Neuroimage 2008;43:29-35.
68. Hakyemez B, Yildirim N, Gokalp G, Erdogan C, Parlak M. The contribution of diffusion-weighted MR imaging to distinguishing typical from atypical meningiomas. Neuroradiology 2006;48:513-20. (Pubitemid 44165285)
69. Weber MA, Zoubaa S, Schlieter M, Juttler E, Huttner HB, Geletneky K et al. Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors. Neurology 2006;66:1899-906. (Pubitemid 44049824)
70. Kremer S, Grand S, Remy C, Esteve F, Lefournier V, Pasquier B et al. Cerebral blood volume mapping by MR imaging in the initial evaluation of brain tumors. J Neuroradiol 2002;29:105-13. (Pubitemid 36215878)
71. Law M, Cha S, Knopp EA, Johnson G, Arnett J, Litt AW. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 2002;222:715-21. (Pubitemid 34215219)
72. Raizer JJ, Koutcher JA, Abrey LE, Panageas KS, DeAngelis LM, Lis E et al. Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma. Journal of neuro-oncology 2005;71:173-80. (Pubitemid 40796301)
73. Soussain C, Hoang-Xuan K. Primary central nervous system lymphoma: an update. Curr Opin Oncol 2009;21:550-8.
74. Chawla S, Zhang Y, Wang S, Chaudhary S, Chou C, O'Rourke DM et al. Proton magnetic resonance spectroscopy in differentiating glioblastomas from primary cerebral lymphomas and brain metastases. J Comput Assist Tomogr 2010;34:836-41.
75. Barkovich AJ. Pediatric Neuroimaging. Philadelphia: Lippincott Williams and Wilkins; 2005.
76. Poretti A, Meoded A, Huisman TA. Neuroimaging of pediatric posterior fossa tumors including review of the literature. J Magn Reson Imaging 2011.
77. Paldino MJ, Faerber EN, Poussaint TY. Imaging tumors of the pediatric central nervous system. Radiol Clin North Am 2011;49:589-616, v.
78. Fruehwald-Pallamar J, Puchner SB, Rossi A, Garre ML, Cama A, Koelblinger C et al. Magnetic resonance imaging spectrum of medulloblastoma. Neuroradiology 2011;53:387-96.
79. Tortori-Donati P, Rossi A. Pediatric neuroradiology. Springer; 2005.
80. Panigrahy A, Bluml S. Neuroimaging of pediatric brain tumors: from basic to advanced magnetic resonance imaging (MRI). J Child Neurol 2009;24:1343-65.
81. Panigrahy A, Nelson MD, Jr., Bluml S. Magnetic resonance spectroscopy in pediatric neuroradiology: clinical and research applications. Pediatr Radiol 2010;40:3-30.
82. Yuh EL, Barkovich AJ, Gupta N. Imaging of ependymomas: MRI and CT. Childs Nerv Syst 2009;25:1203-13.
83. Rossi A, Cama A, Consales A, Gandolfo C, Garre ML, Milanaccio C et al. Neuroimaging of pediatric craniopharyngiomas: a pictorial essay. J Pediatr Endocrinol Metab 2006;19 Suppl 1:299-319.
84. Castillo M, Mukherji SK. Imaging of the pediatric head, neck, and spine. Philadelphia: Lippincott-Raven; 1996.
85. Claus EB, Bondy ML, Schildkraut JM, Wiemels JL, Wrensch M, Black PM. Epidemiology of intracranial meningioma. Neurosurgery 2005;57:1088-95; discussion -95.
86. Zimny A, Sasiadek M. Contribution of perfusion-weighted magnetic resonance imaging in the differentiation of meningiomas and other extra-axial tumors: case reports and literature review. Journal of neuro-oncology 2011;103:777-83.
87. Osborn AG, Barcovich, AJ. Diagnostic Imaging: Brain 2 ed: Lippincott Williams & Wilkins / Amirsys; 2010.
88. Weber DC, Lovblad KO, Rogers L. New pathology classification, imagery techniques and prospective trials for meningiomas: the future looks bright. Curr Opin Neurol 2010;23:563-70.
89. Saloner D, Uzelac A, Hetts S, Martin A, Dillon W. Modern meningioma imaging techniques. Journal of neuro-oncology 2010;99:333-40.
90. Johnson MD, Powell SZ, Boyer PJ, Weil RJ, Moots PL. Dural lesions mimicking meningiomas. Hum Pathol 2002;33:1211-26. (Pubitemid 36020072)
91. Santelli L, Ramondo G, Delia Puppa A, Ermani M, Scienza R, d'Avella D et al. Diffusion-weighted imaging does not predict histological grading in meningiomas. Acta Neurochir (Wien) 2010;152:1315-9; discussion 9.
92. Yamasaki F, Kurisu K, Satoh K, Arita K, Sugiyama K, Ohtaki M et al. Apparent diffusion coefficient of human brain tumors at MR imaging. Radiology 2005;235:985-91. (Pubitemid 40695898)
93. Pavlisa G, Rados M, Pazanin L, Padovan RS, Ozretic D. Characteristics of typical and atypical meningiomas on ADC maps with respect to schwannomas. Clin Imaging 2008;32:22-7. (Pubitemid 350299122)
94. Shino A, Nakasu S, Matsuda M, Handa J, Morikawa S, Inubushi T. Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy. J Neurosurg 1999;91:928-34.
95. Demir MK, Iplikcioglu AC, Dincer A, Arslan M, Sav A. Single voxel proton MR spectroscopy findings of typical and atypical intracranial meningiomas. Eur J Radiol 2006;60:48-55. (Pubitemid 44397385)
96. Qi ZG, Li YX, Wang Y, Geng DY, Li KC, Shen TZ et al. Lipid signal in evaluation of intracranial meningiomas. Chin Med J (Engl) 2008;121:2415-9.
97. Majos C, Aguilera C, Alonso J, Julia-Sape M, Castaner S, Sanchez JJ et al. Proton MR spectroscopy improves discrimination between tumor and pseudotumoral lesion in solid brain masses. AJNR Am J Neuroradiol 2009;30:544-51.
98. Evans DG. Neurofibromatosis 2 [Bilateral acoustic neurofibromatosis, central neurofibromatosis, NF2, neurofibromatosis type II]. Genet Med 2009;11:599-610.
99. MacCollin M, Chiocca EA, Evans DG, Friedman JM, Horvitz R, Jaramillo D et al. Diagnostic criteria for schwannomatosis. Neurology 2005;64:1838-45. (Pubitemid 40800695)
100. Consales A, Rossi A, Nozza P, Ravegnani M, Garre ML, Cama A. Intracerebral schwannoma in a child. Br J Neurosurg 2010;24:306-8.
101. Jian BJ, Bloch OG, Yang I, Han SJ, Aranda D, Parsa AT. A comprehensive analysis of intracranial chordoma and survival: a systematic review. Br J Neurosurg 2011;25:446-53.
102. Nagasawa D, Yew A, Safaee M, Fong B, Gopen Q, Parsa AT et al. Clinical characteristics and diagnostic imaging of epidermoid tumors. J Clin Neurosci 2011;18:1158-62.
103. Elwell VA, Carney L, Johns P, Grieve JP. Dural infiltration of metastatic Hodgkin's lymphoma. Br J Neurosurg 2008;22:439-40. (Pubitemid 351878615)
104. Liu P, Saida Y, Yoshioka H, Itai Y. MR imaging of epidermoids at the cerebellopontine angle. Magn Reson Med Sci 2003;2:109-15.
105. Nakao Y, Nonaka S, Yamamoto T, Oyama K, Esaki T, Tange Y et al. Malignant transformation 20 years after partial removal of intracranial epidermoid cyst-case report. Neurol Med Chir (Tokyo) 2010;50:236-9.
106. Stewart JG, Sawrie SM, Bag A, Han X, Fiveash JB. Management of brain metastases. Curr Treat Options Neurol 2010;12:334-46.
107. Chamberlain MC. Leptomeningeal metastasis. Curr Opin Oncol 2010;22:627-35.
108. Chamberlain MC. Lymphomatous meningitis in primary central nervous system lymphoma. Neurosurg Focus 2006;21:E6.
109. Clarke JL, Perez HR, Jacks LM, Panageas KS, Deangelis LM. Leptomeningeal metastases in the MRI era. Neurology 2010;74:1449-54.
110. Lui YW, Malhotra A, Farinhas JM, Dasari SB, Weidenheim K, Freeman K et al. Dynamic perfusion MRI characteristics of dural metastases and meningiomas: a pilot study characterizing the first-pass wash-in phase beyond relative cerebral blood volume. AJR Am J Roentgenol 2011;196:886-90.